A consultation is required to determine medical eligibility and ensure peptide therapy is appropriate given the health history, goals, and lab results
Long-term relationships with well-known peptide makers provide supply security, which is very important in competitive therapeutic areas where material shortages can delay the release of new products
(1994) [9] evaluated GHK-Cu peptide complex gel in subjects with neuropathic plantar ulcers, employing a randomized placebo-controlled design with a standardized sharp debridement protocol
This overcomes the limitations of individual trials small sample sizes, specific populations, or methodological quirks
Glucagon-like peptide-1 7-36: a physiological incretin in man
194 In laboratory animals, EGCG inhibited platelet aggregation, prevented thrombus formation in injured vessels, and prolonged bleeding time